Phosphorylation of carbovir enantiomers by cellular enzymes determines the stereoselectivity of antiviral activity
- J Biol Chem. 1992 Oct 15;267(29):21220-4.
- 1. Division of Experimental Therapy, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709.
Two enantiomers of carbovir, a carbocyclic analog of 2',3'-dideoxyguanosine, were compared with respect to their phosphorylation and the phosphorylation of their nucleotides by mammalian Enzymes. 5'-Nucleotidase catalyzed the phosphorylation of (-)-carbovir, which is active against HIV (human immunodeficiency virus), but did not phosphorylate (+)-carbovir. (-)-Carbovir monophosphate was 7,000 times more efficient as a substrate for GMP kinase than was (+)-carbovir monophosphate. Pyruvate Kinase, phosphoglycerate kinase, and Creatine Kinase phosphorylated both enantiomers of carbovir diphosphate at similar rates. Nucleoside-diphosphate kinase preferentially phosphorylated the (-)-enantiomer. Both enantiomers of carbovir triphosphate were substrates and alternative substrate inhibitors of HIV Reverse Transcriptase. Thus, the contrasting HIV-inhibitory activities of carbovir enantiomers were due to differential phosphorylation by cellular Enzymes and not due to enantioselectivity of HIV Reverse Transcriptase.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Infection